02 Sep 2021
Adcock Ingram’s turnover increases by 6% with increased demand for immune-boosters during COVID-19
By Staff Writer
The Adcock Ingram Group delivered a healthy set of results in the year ended 30 June 2021, with turnover increasing by 6%, despite the effects of the COVID-19 pandemic. ‘Adcock Ingram delivered these results under challenging trading and operating conditions due to the continued impact and uncertainty of the COVID-19 pandemic. Despite these complexities, the...
